Latest News - LabCorp
Top Corporates Hub
LabCorp
Cofactor Genomics Announces Strategic Investment by Labcorp and Ascension Ventures to Fuel Expansion of Its OncoPrism® Immunotherapy Diagnostic Across U.S. Cancer Care Networks
15.12.2025 15:00
ST. LOUIS, December 15, 2025--Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures. The financing is intended to accelerate Cofactor’s nationwide expansion and broaden patient access to its immunotherapy-response diagnostics.
Is the Options Market Predicting a Spike in Labcorp Holdings Stock?
15.12.2025 14:00
Investors need to pay close attention to LH stock based on the movements in the options market lately.
How Is Labcorp Holdings' Stock Performance Compared to Other Healthcare Stocks?
12.12.2025 14:19
Despite Labcorp Holdings’ underperformance relative to its industry peers, Wall Street analysts remain strongly optimistic about the stock’s prospects.
Labcorp (LH) Valuation Check After Steady Share Price Climb and Solid Total Return
09.12.2025 09:09
Labcorp Holdings (LH) has quietly outperformed many healthcare peers this year, and the stock’s recent move has investors asking whether steady earnings growth and diagnostics demand can keep driving gains from here. See our latest analysis for Labcorp Holdings. That steady backdrop has helped Labcorp’s share price grind higher to around $259.94 this year, with a solid year to date share price return and an 11.4 percent one year total shareholder return suggesting momentum is constructive...
Is Labcorp Still Attractively Priced After Strategic Refocusing and Strong Multi Year Gains?
09.12.2025 03:09
If you are wondering whether Labcorp Holdings is still attractively priced today, or if most of the upside has already been captured, you are in the right place to explore what the market might be overlooking. The stock has eased off slightly in the last week, down 2.9%. It is still up 2.9% over the last month, 13.9% year to date and 11.4% over the past year, with longer term gains of 38.0% over three years and 55.2% over five years that hint at a steadily compounding story. Recent headlines...
CHS sells lab assets to Labcorp for $194M
04.12.2025 07:17
The deal, first announced in July, includes outreach laboratory services in 13 states. CHS will continue to operate inpatient and emergency department labs.
Should You Continue to Hold LH Stock in Your Portfolio?
02.12.2025 12:53
Labcorp expands in specialty testing and ramps up acquisitions, but macro pressures and currency headwinds complicate its growth outlook.
Labcorp Appoints Victor Bulto to Board of Directors
24.11.2025 13:30
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the appointment of Victor Bulto, a seasoned pharmaceutical executive and member of Novartis' executive leadership team, to its Board of Directors, effective December 1, 2025.
Labcorp (LH): Evaluating Valuation After Breakthroughs in Cancer Diagnostics and AI-Powered Pathology
24.11.2025 03:12
Labcorp Holdings (LH) is drawing attention after its Plasma Detect assay was featured in two respected medical journals. The company’s digital pathology joint initiative with Lunit also made headlines at recent oncology conferences. See our latest analysis for Labcorp Holdings. Momentum has been building for Labcorp Holdings over 2025, with investor optimism fueled by advances in diagnostics and AI partnerships. The stock’s strong 1-year total shareholder return of 12.1% reflects both robust...
Labcorp® Plasma Detect™ Clinical Studies Featured in Nature Medicine and Clinical Cancer Research
19.11.2025 12:04
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced Labcorp Plasma Detect, a tumor-informed, blood-based assay used to detect molecular residual disease (MRD) from circulating tumor DNA (ctDNA), was featured in two recent peer-reviewed publications – Nature Medicine and Clinical Cancer Research.
Labcorp Holdings' (NYSE:LH) Dividend Will Be $0.72
11.11.2025 11:06
Labcorp Holdings Inc. ( NYSE:LH ) has announced that it will pay a dividend of $0.72 per share on the 11th of December...
Labcorp’s Q3 Earnings Call: Our Top 5 Analyst Questions
04.11.2025 05:36
Labcorp’s third quarter results met Wall Street’s revenue expectations, but the market responded negatively, reflecting investor concerns about profitability and future growth levers. Management attributed the quarter’s performance to robust organic growth in its Diagnostics segment—especially through increased demand for specialty and genetic testing platforms like Invitae. CEO Adam Schechter explained that "margin for the quarter improved 100 basis points, driven by Diagnostics," and highlight
Labcorp (LH) Net Margin Surges to 6.2%, Reinforcing Bullish Earnings Turnaround Narrative
30.10.2025 04:33
Labcorp Holdings (LH) posted a net profit margin of 6.2% for the period, up from 3.4% a year ago, as earnings surged 96.4% year-over-year. This is well above the company's five-year average despite a longer-term earnings decline of 30.6% per year. Shares sit at $248.14, notably below the estimated fair value of $557.86. The current price-to-earnings ratio of 24.1x is higher than peer and industry averages. Investors are eyeing a potential turnaround as earnings are forecast to grow 14% per...
Fertility Test Market Report 2025-2033, with Profiles of Quest Diagnostics, Mayo Clinic Laboratories, Ovation Fertility, Illume Fertility, Proov, BioMerieux, Labcorp, CCRM Fertility, and Maven Clinic
21.10.2025 14:00
Opportunities in the global fertility test market include rising demand due to lifestyle changes, delayed pregnancies, and increasing infertility rates. Growing awareness and acceptance of fertility testing, alongside the prevalence of reproductive disorders, also drive market expansion across diverse demographics globally. Fertility Test Market Fertility Test Market Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "Fertility Test Market Size, Share & Trends Analysis Report by Test Type (Ovulation
Labcorp Holdings Inc. (LH) Hits Fresh High: Is There Still Room to Run?
21.10.2025 13:15
Labcorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Labcorp (LH): Assessing Valuation After Monthlong Share Price Gains and Analyst Target Approaches
20.10.2025 00:14
Labcorp Holdings (LH) shares inched up about 1% today, adding to their steady gains over the past month. With recent momentum continuing, investors are considering what factors could drive further moves in the healthcare giant’s stock. See our latest analysis for Labcorp Holdings. Labcorp Holdings has delivered a robust run this year, with the share price rallying more than 25% year to date and momentum accelerating over the past quarter. Investors have seen an impressive 34% total...
Labcorp (LH) Upgraded to Buy: What Does It Mean for the Stock?
09.10.2025 16:00
Labcorp (LH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Strategic Deals Drive TEM Growth Amid Competition: Buy, Hold or Sell?
09.10.2025 14:54
Tempus AI sharpens its edge in precision medicine with key acquisitions, strong R&D launches, and improving financials amid rising competition.